Regenxbio (RGNX) Short-term Investments (2015 - 2025)

Regenxbio's Short-term Investments history runs 11 years deep, the most recent figure standing at $195.6 million for Q4 2025.

• In Q4 2025, Short-term Investments rose 10.41% year-over-year to $195.6 million; the TTM figure through Dec 2025 stood at $195.6 million (up 10.41% YoY), while the FY2025 annual figure was $195.6 million, up 10.41% from the prior year.
• Short-term Investments was $195.6 million for Q4 2025 at Regenxbio, down from $215.4 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $281.6 million in Q2 2022 to a low of $111.5 million in Q3 2021.
• Historically, Short-term Investments has averaged $206.8 million across 5 years, with a median of $220.6 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Short-term Investments soared 139.31% in 2022, then sank 38.97% in 2025.
• A 5-year view of Short-term Investments shows it stood at $112.2 million in 2021, then surged by 138.52% to $267.7 million in 2022, then fell by 10.07% to $240.7 million in 2023, then fell by 26.41% to $177.2 million in 2024, then climbed by 10.41% to $195.6 million in 2025.
• The last three Short-term Investments figures came in at $195.6 million (Q4 2025), $215.4 million (Q3 2025), and $243.7 million (Q2 2025), per Business Quant data.